MELISSA BELLO: Open Payments
NPI 1477033801 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 12 payments from 6 companies in 2025. Trend: 2023 $172 · 2024 $659 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $91 |
| Lilly USA, LLC | 3 | $63 |
| REVANCE THERAPEUTICS, INC. | 1 | $56 |
| Amgen Inc. | 2 | $45 |
| Averitas Pharma Inc. | 1 | $31 |
| Impulse Dynamics (USA) Inc. | 1 | $21 |
Products named: ELIQUIS, DAXXIFY, MOUNJARO, QUTENZA, REPATHA, ZEPBOUND, Optimizer, OTEZLA.
Industry payments across FL — which companies pay providers there.
